Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
35.53
-0.55 (-1.52%)
Jan 28, 2026, 4:00 PM EST - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 10.03%, Roche Holding AG at 5.11%, UnitedHealth Group at 4.58%, Thermo Fisher Scientific at 4.34%, and Johnson & Johnson at 4.30%.
Total Holdings
45
Top 10 Percentage
46.59%
Asset Class
Equity
ETF Category
Health
Assets
57.77M
PE Ratio
23.54
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.03% |
| 2 | RHHBY | Roche Holding AG | 5.11% |
| 3 | UNH | UnitedHealth Group Incorporated | 4.58% |
| 4 | TMO | Thermo Fisher Scientific Inc. | 4.34% |
| 5 | JNJ | Johnson & Johnson | 4.30% |
| 6 | LON: AZN | AstraZeneca PLC | 4.29% |
| 7 | MRK | Merck & Co., Inc. | 3.89% |
| 8 | CPH: NOVO.B | Novo Nordisk A/S | 3.58% |
| 9 | GILD | Gilead Sciences, Inc. | 3.32% |
| 10 | SWX: NOVN | Novartis AG | 3.15% |
| 11 | ABT | Abbott Laboratories | 3.13% |
| 12 | BSX | Boston Scientific Corporation | 2.98% |
| 13 | DHR | Danaher Corporation | 2.94% |
| 14 | MDT | Medtronic plc | 2.90% |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 2.80% |
| 16 | ABBV | AbbVie Inc. | 2.79% |
| 17 | BBIO | BridgeBio Pharma, Inc. | 2.24% |
| 18 | AMGN | Amgen Inc. | 2.12% |
| 19 | REGN | Regeneron Pharmaceuticals, Inc. | 1.95% |
| 20 | BMY | Bristol-Myers Squibb Company | 1.88% |
| 21 | RVMD | Revolution Medicines, Inc. | 1.86% |
| 22 | MCK | McKesson Corporation | 1.79% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.72% |
| 24 | EW | Edwards Lifesciences Corporation | 1.53% |
| 25 | ISRG | Intuitive Surgical, Inc. | 1.53% |
As of Jan 26, 2026